LP2, a cyclic angiotensin-(1−7) analog extended with an N-terminal D-lysine, impairs growth of patient-derived xenografts of colorectal carcinoma in mice

MLA

Namsolleck, P., et al. “LP2, a Cyclic Angiotensin-(1−7) Analog Extended with an N-Terminal D-Lysine, Impairs Growth of Patient-Derived Xenografts of Colorectal Carcinoma in Mice.” Peptides, vol. 160, Feb. 2023, p. 170920. EBSCOhost, https://doi.org/10.1016/j.peptides.2022.170920.

APA

Namsolleck, P., de Vries, L., & Moll, G. N. (2023). LP2, a cyclic angiotensin-(1−7) analog extended with an N-terminal D-lysine, impairs growth of patient-derived xenografts of colorectal carcinoma in mice. Peptides, 160, 170920. https://doi.org/10.1016/j.peptides.2022.170920

Chicago

Namsolleck, P., L. de Vries, and G. N. Moll. 2023. “LP2, a Cyclic Angiotensin-(1−7) Analog Extended with an N-Terminal D-Lysine, Impairs Growth of Patient-Derived Xenografts of Colorectal Carcinoma in Mice.” Peptides 160 (February): 170920. doi:10.1016/j.peptides.2022.170920.